GILEAD SCIENCES, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

GILEAD SCIENCES, INC. reported Cash And Cash Equivalents At Carrying Value of $5.41 billion for the year ending 2022.

  • GILEAD SCIENCES, INC. showed an increase of +1.4% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from GILEAD SCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 22, 2023.
  • XBRL data for this metric is available from 2006 to 2022 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 17 years of available data (2006 to 2022), GILEAD SCIENCES, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 563.2%.
  • Historical annual values: Fiscal year 2022: $5.41 billion | Fiscal year 2021: $5.34 billion | Fiscal year 2020: $6.00 billion | Fiscal year 2019: $11.63 billion | Fiscal year 2018: $17.94 billion | Fiscal year 2017: $7.59 billion | Fiscal year 2016: $8.23 billion | Fiscal year 2015: $12.85 billion | Fiscal year 2014: $10.03 billion | Fiscal year 2013: $2.11 billion | Fiscal year 2012: $1.80 billion | Fiscal year 2011: $9.88 billion | Fiscal year 2010: $907.88 million | Fiscal year 2009: $1.27 billion | Fiscal year 2008: $1.46 billion | Fiscal year 2007: $968.09 million | Fiscal year 2006: $816.01 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: